Self-expanding stents improve positioning in primary angioplasty

Original title: Self-Expanding Versus Balloon-Expandable Stents in Acute Myocardial Infarction: Results From the APPOSITION II Study Reference: Robert-Jan van Geuns et al. J Am Coll Cardiol Intv 2012;5:1209–19

Acute myocardial infarction is associated with vasoconstriction and thrombus occlusion. Resolution of these two points during the first hours after primary angioplasty can lead to poor extension and poor positioning of the stent implanted with the probable risk of thrombosis and restenosis. 

On the other hand, aggressive implantation could cause distal embolization. This study tested the hypothesis that self-expanding stents are more effective than balloon-expandable stents to reduce poor positioning after primary angioplasty. We randomized 80 patients with ST elevation acute myocardial infarction (STEMI) who were receiving primary angioplasty with a self-expandable stent (STENTYS, Paris, France) or a balloon-expandable stent (Vision, Abbott Vascular, Santa Clara, California, or Driver, Medtronic, Minneapolis, Minnesota). 

The primary endpoint was the proportion of the struts poor positioning after 3 days of implantation using optical coherence tomography (OCT). The secondary endpoint was major cardiac events such as cardiac death, recurrent infarction or emergency bypass surgery. After 3 days of implantation, the self-expanding stents had a lower percentage of poor strut positioning compared with balloon-expandable (0.58% versus 5.46%, respectively, P <0.001). The major cardiac events at 6 months were not significantly different between groups.

Conclusion 

Self-expanding stents had a lower incidence of poor strut positioning using OCT than balloon-expandable stents after primary angioplasty.

Editorial Comment:

This study lacks sufficient power to show the clinical differences between the two types of stent, however it does show the feasibility and safety of self-expanding stents that have already been tested at bifurcations. A particularly striking feature is the lack of data on the degree of TIMI 3 and Blush post implant. 

Courtesy of Dr. Gustavo Hidalgo.
Fellowship of Interventional Cardiology.
Fundación Favaloro.

Dr. Gustavo Hidalgo para SOLACI.ORG

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...